Arad, A.;                     Katz, M.;                     Lebel, E.;                     Kalish, Y.;                     Assayag, M.;                     Avni, B.;                     Elias, S.;                     Grisariu, S.;                     Shai, E.;                     Kfir-Erenfeld, S.;     
    et al.    High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). Cancers 2025, 17, 3551.
    https://doi.org/10.3390/cancers17213551
    AMA Style
    
                                Arad A,                                 Katz M,                                 Lebel E,                                 Kalish Y,                                 Assayag M,                                 Avni B,                                 Elias S,                                 Grisariu S,                                 Shai E,                                 Kfir-Erenfeld S,         
        et al.        High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). Cancers. 2025; 17(21):3551.
        https://doi.org/10.3390/cancers17213551
    
    Chicago/Turabian Style
    
                                Arad, Ariela,                                 Maya Katz,                                 Eyal Lebel,                                 Yosef Kalish,                                 Miri Assayag,                                 Batia Avni,                                 Shlomo Elias,                                 Sigal Grisariu,                                 Ela Shai,                                 Shlomit Kfir-Erenfeld,         
         and et al.        2025. "High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T)" Cancers 17, no. 21: 3551.
        https://doi.org/10.3390/cancers17213551
    
    APA Style
    
                                Arad, A.,                                 Katz, M.,                                 Lebel, E.,                                 Kalish, Y.,                                 Assayag, M.,                                 Avni, B.,                                 Elias, S.,                                 Grisariu, S.,                                 Shai, E.,                                 Kfir-Erenfeld, S.,                                 Asherie, N.,                                 Gatt, M. E.,                                 Stepensky, P.,                                 & Zimran, E.        
        
        (2025). High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). Cancers, 17(21), 3551.
        https://doi.org/10.3390/cancers17213551